Disclosures for "Complementary Antisense Oligonucleotide Treatment and Precision Sodium Channel Modulation for Early Onset SCN2A Developmental and Epileptic Encephalopathy: Emergency Use Case in a Preterm Infant with Refractory Status Epilepticus "
-
Dr. Frizzo has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Frizzo has stock in Praxis Precision Medicines.
-
Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharming Group. The institution of Dr. Wagner has received research support from Novartis. Dr. Wagner has received personal compensation in the range of $500-$4,999 for serving as a speaker with Jazz Pharmaceutics. Dr. Wagner has received personal compensation in the range of $0-$499 for serving as a speaker with UCB. Dr. Wagner has received personal compensation in the range of $0-$499 for serving as a speaker with Desitin.
-
Dr. Zaddach has nothing to disclose.
-
The institution of Prof. Nussbaum has received research support from German Research Foundation . Prof. Nussbaum has received publishing royalties from a publication relating to health care. Prof. Nussbaum has received personal compensation in the range of $50,000-$99,999 for serving as a Speaker at scientific conference with Chiesi.
-
Dr. Berecki has nothing to disclose.
-
Prof. Flemmer has nothing to disclose.
-
Prof. Heinen has nothing to disclose.
-
Mr. Spar has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Prof. Staudt has nothing to disclose.
-
Mr. Tacke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuraxpharm. Mr. Tacke has received publishing royalties from a publication relating to health care.
-
Dr. Wolff has nothing to disclose.
-
Dr. Fazeli has nothing to disclose.
-
Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care.
-
Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Desitin. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Borggraefe has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme.